Biopharma VC Funding Spreading To More Towns Outside Cambridge: MassBio Report
Courtesy of Newmark Barings acquired One Patriots Park, a 144K SF Class-A life sciences asset in Bedford. Venture capital investment in Massachuset...
Courtesy of Newmark Barings acquired One Patriots Park, a 144K SF Class-A life sciences asset in Bedford. Venture capital investment in Massachusetts' life sciences industry is spreading to cities and towns outside of the traditional Cambridge hub, a new report found, creating more opportunity for real estate growth in the suburbs. Of the $8.7B in venture capital funding to biopharma companies in the state last year, 51% went to companies outside of Cambridge, up from 42% in 2021, according to MassBio's 2022 Massachusetts Biopharma Funding Report.